For the President to maintain popularity and be humankind’s hero, he must deploy the vaccine for most of the world without a hitch.
With little hope for the amateur spy, a federal agent then tries to turn a Genyologen employee into an asset.
The espionage has brought suspicion from the outset. Under test, the inside agent must find a cure before he succumbs to the deadly virus.
Corporate spy, Ray Zy-Dyent, interviews at a major pharmaceutical competitor to access incriminating evidence for the government.
The government recruits a scientist to go undercover as a spy to gather information about a serum to cure the rampant disease.
The largest pharma-tech company weighs the advantages of a consortium to battle a global health crisis.
A major entity within the pharmaceutical consortium discusses the ramifications of the President’s international speech.
Premiere: As the year 2100 approaches, this world teeters on the edge of a new era—or human extinction in this novella miniseries.
All alone, with limited resources, and fearful that others are tracking him, Dennis tries his best to maintain his sanity without advanced technology.
Dennis makes a risky move for assistance while trying to evade authorities. Meanwhile, Abigail has a moment of clarity regarding their plight.
Before cutting loose from society entirely, Dennis and Abigail explore ways to stay off the grid. Do they blend in with crowds or remain on backstreets?
With Dennis and Abigail in the wind, their boss tries to piece together omissions in their data and track them down.
Without great options after returning home early from a doctor’s visit, Dennis contemplates life on the run while access to technology remains.
Featured authors and reviewers
This information does not constitute professional medical care or legal advice. Discuss personal concerns with your doctor or legal advisor.